migalastat has been researched along with thiourea in 1 studies
| Studies (migalastat) | Trials (migalastat) | Recent Studies (post-2010) (migalastat) | Studies (thiourea) | Trials (thiourea) | Recent Studies (post-2010) (thiourea) |
|---|---|---|---|---|---|
| 143 | 14 | 89 | 6,959 | 46 | 1,737 |
| Protein | Taxonomy | migalastat (IC50) | thiourea (IC50) |
|---|---|---|---|
| Urease | Canavalia ensiformis (jack bean) | 0.56 | |
| Serine-protein kinase ATM | Homo sapiens (human) | 0.2 | |
| Serine/threonine-protein kinase ATR | Homo sapiens (human) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drury, JE; García Fernández, JM; Higaki, K; Johnson, JL; Lieberman, RL; Mellet, CO; Mena-Barragán, T; Nakasone, N; Nanba, E; Ninomiya, H; Ohno, K; Sakuraba, H; Suzuki, Y; Tsukimura, T; Yu, Y | 1 |
1 other study(ies) available for migalastat and thiourea
| Article | Year |
|---|---|
Molecular basis of 1-deoxygalactonojirimycin arylthiourea binding to human α-galactosidase a: pharmacological chaperoning efficacy on Fabry disease mutants.
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Animals; Autophagy; Chlorocebus aethiops; COS Cells; Crystallography, X-Ray; Enzyme Stability; Fabry Disease; Fibroblasts; Humans; Molecular Docking Simulation; Mutation; Protein Transport; Thiourea; Trihexosylceramides | 2014 |